• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sucampo Pharmaceuticals Inc

+ Add to Watchlist

R3A:GR

5.207 EUR 0.016 0.31%

As of 11:55:56 ET on 08/27/2014.

Snapshot for Sucampo Pharmaceuticals Inc (R3A)

Open: 5.245 Day's Range: 5.145 - 5.245 Volume: 0
Previous Close: 5.223 52wk Range: 4.091 - 7.993 1-Yr Rtn: +18.15%

Stock Chart for R3A

No chart data available.
  • R3A:GR 5.207
  • 1D
  • 1M
  • 1Y
5.223
Interactive R3A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for R3A

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 36.1530
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.1900
Est. PEG Ratio -
Market Cap (M EUR) 230.64
Shares Outstanding (M) 44.29
30 Day Average Volume 40
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for R3A

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for R3A

Sucampo Pharmaceuticals, Inc. researches and develops drugs based on protones, which are derived from functional fatty acids. The Company produces a prescription drug for the treatment of chronic idiopathic constipation.

Peter GreenleafChief Executive OfficerCary J ClaiborneChief Financial Officer
Andrew P SmithPrincipal Accounting OfficerThomas J KnappExec VP/Chief Legal Ofcr/Secy
More Company Profile & Key Executives for R3A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil